Frequently Asked Questions

GLOW and KLOW are research peptides that are sometimes combined, but there are several reasons why co-administration may be inadvisable. First, each peptide has its own optimal dosing schedule, and mixing them can make it difficult—or even impossible—to adjust doses individually for maximal effect. Second, GHK-Cu, a component of these blends, contains copper ions, which are capable of catalyzing oxidation reactions that may degrade or reduce the potency of other peptides in the mixture. For these reasons, it is generally recommended that, if you choose to work with these research peptides, they be purchased and administered separately to ensure stability and proper dosing.